Apyx Medical (APYX) Accumulated Expenses (2010 - 2026)

Apyx Medical has reported Accumulated Expenses for 17 years, with the latest figure at $6.4 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 6.65% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (down 6.65% YoY), and the FY2025 full-year result was $8.2 million, up 5.97% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $6.4 million, down from $8.2 million in the prior quarter.
• The five-year high for Accumulated Expenses was $9.7 million in Q4 2023, with the low at $6.4 million in Q1 2026.
• Historically, Accumulated Expenses has averaged $7.9 million across 5 years, with a median of $7.9 million in 2023.
• Annual changes were most pronounced in 2022 — Accumulated Expenses climbed 24.64% — and 2024, when it fell 19.77%.
• Apyx Medical's Accumulated Expenses stood at $8.9 million in 2022, then grew by 8.21% to $9.7 million in 2023, then fell by 19.77% to $7.8 million in 2024, then increased by 5.97% to $8.2 million in 2025, then declined by 22.36% to $6.4 million in 2026.
• The last three Accumulated Expenses figures came in at $6.4 million (Q1 2026), $8.2 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.